Ajinomoto Bio-Pharma Services: AstraZeneca manufacturing agreement
Ajinomoto Bio-Pharma Services has inked a manufacturing expansion deal with AstraZeneca to include drug product manufacturing. The agreement expands the scope of the companies’ arrangement to include aseptic fill finish services at Ajinomoto’s San Diego, California facility, as well as small-molecule manufacturing in Belgium.
Magnus Busch, global account manager with Ajinomoto, said, “We are excited to expand our manufacturing agreement with AstraZeneca and to support them with additional service offerings. This expanded agreement builds on our commitment to be a leading, trusted, innovative partner to our clients.”
